PA-04

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePA-04

Drug Alias NamePseudomonal lung infection therapy (EPIcyte)transport molecules (EPIcyte)PA-04

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsPneumoniaPseudomonas Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEPIcyte Pharmaceutical Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEPIcyte Pharmaceutical Inc

Active IndicationsN/A

Inactive IndicationsPneumoniaPseudomonas Infections

Other Information

ATC CodeN/A